Showing 8961-8970 of 23044 results for "".
Bridging Gaps in Kidney Care: How to Improve Referrals, Transitions, and Coordination
https://reachmd.com/programs/clinicians-roundtable/bridging-gaps-in-kidney-care-how-to-improve-referrals-transitions-and-coordination/37224/From delayed referrals to fragmented care, health systems face several barriers to delivering timely, coordinated kidney care. That’s why Dr. Mallika Mendu joins us to highlight three critical areas for improvement: promoting early, guideline-based referrals from primary care, enhancing coordinationReshaping Dialysis Care: How New Payment Models Focus on Quality and Outcomes
https://reachmd.com/programs/clinicians-roundtable/reshaping-dialysis-care-how-new-payment-models-focus-on-quality-and-outcomes/37223/As kidney care moves beyond volume-based reimbursement, models like Kidney Care Choices are driving meaningful change by prioritizing clinical outcomes, home dialysis starts, and transplant access. Here to discuss how these policy shifts have advanced value-based care and why sustained investment anJournal Club: Combination Therapy With Dupilumab and Upadacitinib
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-combination-therapy-with-dupilumab-and-upadacitinib/32408/Neal Bhatia, MD, FAAD, and Ted Lain, MD, MBA, FAAD, discuss the International Journal of Dermatology article “Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis,” and their own experiences with similar treatment strategies.Moving Beyond Immunosuppressive Therapy in IgAN
https://reachmd.com/programs/clinicians-roundtable/moving-beyond-immunosuppressive-therapy-in-igan/37218/Although immunosuppressive therapy has been the backbone of IgA nephropathy (IgAN) treatment, this type of approach comes with several challenges. Here to share how non-immunosuppressive treatments could help revolutionize the IgAN treatment landscape is Dr. Gates B. Colbert, Assistant Clinical ProfTiming Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
https://reachmd.com/programs/neurofrontiers/timing-matters-influenza-vaccination-response-in-ms-patients-on-ofatumumab/32826/Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
https://reachmd.com/programs/clinicians-roundtable/beyond-disease-control-pros-with-odronextamab-in-rr-follicular-lymphoma/37208/In relapsed or refractory follicular lymphoma, disease control is only part of the equation. In this AudioAbstract, ReachMD's Ryan Quigley explores patient-reported outcomes from the ELM-2 trial, revealing that odronextamab not only delivers high response rates but also helps preserve—and in some caFrom Policy to Practice: What the WHO Lung Health Resolution Means for Lung Cancer Care
https://reachmd.com/programs/project-oncology/from-policy-to-practice-what-the-who-lung-health-resolution-means-for-lung-cancer-care/36561/The World Health Organization's new Integrated Lung Health Resolution is the first to explicitly include lung cancer within a global lung health framework. In this AudioAbstract, ReachMD's Ryan Quigley explains what this means for screening, early diagnosis, care pathways, and equitable access to trRepeat mt-sDNA Screening for Colorectal Cancer in Underserved Populations
https://reachmd.com/programs/clinicians-roundtable/repeat-mt-sdna-screening-demonstrates-strong-adherence-in-underserved-populations/36404/Subcutaneous Cancer Immunotherapy at Home: Transforming Trials and Patient Care
https://reachmd.com/programs/project-oncology/subcutaneous-cancer-immunotherapy-at-home-transforming-trials-and-patient-care/35772/As cancer treatment continues to evolve, at-home subcutaneous immunotherapy is at the forefront of decentralized care and research. Here to share his insights on how this delivery model could impact clinical trials and cancer care is Dr. Jorge Nieva, Associate Professor of Clinical Medicine at the UManaging Iatrogenic Colon Perforations: Strategies and Considerations
https://reachmd.com/programs/gi-insights/managing-iatrogenic-colon-perforations-strategies-and-considerations/32747/Colonic perforations during colonoscopy are rare, but when they occur, taking swift and informed action is critical, particularly to avoid surgical intervention. Joining Dr. Peter Buch to offer his insights on perforation prevention, risk-reduction techniques, and repair strategies is Dr. Mark Benso